COMMUNIQUÉS West-GlobeNewswire

Aleafia Health Announces new President of Clinic Operations

15/02/2019 - 13:00

White to Lead Integration of Canabo Medical Clinics and GrowWise Health Post-closing of Emblem Acquisition Previously the COO of Canada’s Largest Multidisciplinary Clinic Network TORONTO, Feb. 15, 2019 (GLOBE NEWSWIRE [...]

Cerecor Announces CERC-301 Granted U.S. Patent

15/02/2019 - 12:30

ROCKVILLE, Md., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments in rare and orphan diseases in [...]

Achaogen Announces Pricing of $15 Million Underwritten Public Offering

15/02/2019 - 12:11

SOUTH SAN FRANCISCO, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]

Hemispherx Biopharma Announces Commencement of Rights Offering Subscription Period

15/02/2019 - 12:00

OCALA, Fla., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical [...]

RavenQuest to Exclusively Sell Seeds From Award-Winning Amsterdam-Based Seed Producer Dutch Passion

15/02/2019 - 12:00

VANCOUVER, British Columbia, Feb. 15, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) is pleased to announce it has entered into a Letter of [...]

Notice to convene Herantis Pharma Plc's Extraordinary General Meeting of shareholders

15/02/2019 - 08:31

Notice to convene Herantis Pharma Plc's Extraordinary General Meeting of shareholders Herantis Pharma Plc Company release 15 February 2019 at 9:30 am NOTICE TO CONVENE HERANTIS PHARMA PLC'S EXTRAORDINARY GENERAL MEETING [...]

Ellens dotterbolag Ellen Asia Ltd samarbetsavtal med Humanwell Healthcare Group i Kina har inte uppnått önskat resultat under 2018

15/02/2019 - 08:30

Ellen Asia Ltd som ägs till 70 procent av Ellen AB och 30 procent av samarbetspartnern Foundation Asia Pacific Ltd., tecknade ett samarbetsavtal 2 februari 2018 med Humanwell Healthcare Group om försäljning i Kina. [...]

Immunicum AB (publ) Year-End Report 2018

15/02/2019 - 08:01

Press Release 15 February 2019 Immunicum AB (publ) Year-End Report 2018 Validations from different corners of the industry Significant Events During the Fourth Quarter Immunicum announced a collaboration with Merck KGaA [...]

Herantis Pharma Plc is planning a directed share issue and prepares for a contemplated secondary listing on the First North Stockholm marketplace

15/02/2019 - 08:01

Herantis Pharma Plc is planning a directed share issue to a limited number of investors and the company's directors and prepares for a contemplated secondary listing on the First North Stockholm marketplace Herantis [...]

MDxHealth (R): MDxHealth Announces Presentation of Positive Data for SelectMDx and ConfirmMDx in Prostate Cancer Diagnosis

15/02/2019 - 07:01

NEWS RELEASE Data to be Presented at the Annual ASCO Genitourinary Cancers Symposium Data to further support clinical adoption of SelectMDx and ConfirmMDx IRVINE, CA, and HERSTAL, BELGIUM - February 15, 2019 - MDxHealth [...]

MDxHealth (R) : MDxHealth annonce la présentation des données positives de SelectMDx et de ConfirmMDx dans le diagnostic du cancer de la prostate

15/02/2019 - 07:01

COMMUNIQUÉ DE PRESSE Les données, visant à encourager l'adoption clinique de SelectMDx et de ConfirmMDx, seront présentées lors du symposium annuel de l'ASCO sur les cancers génito-urinaires IRVINE, CA, et HERSTAL, [...]

La Jolla Pharmaceutical Company Announces Data Presentations at the Society of Critical Care Medicine’s 48th Critical Care Congress

15/02/2019 - 01:18

New Data on GIAPREZA™ (angiotensin II) to be Presented in Oral Sessions at the Society of Critical Care Medicine’s 48th Critical Care Congress SAN DIEGO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company [...]

SeaSpine to Report Fourth Quarter and Full Year 2018 Financial Results on February 27, 2019

15/02/2019 - 01:01

CARLSBAD, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today [...]

Lexington Biosciences Announces Termination of Private Placement

14/02/2019 - 23:05

VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces that, despite numerous attempts over the past 9 months, it [...]

Orion's and Bayer's darolutamide shows substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the ARAMIS trial

14/02/2019 - 22:46

Orion Corporation Press Release Communications 14 February 2019 at 11.45 p.m. EET Orion's and Bayer's darolutamide shows substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the [...]

Anchiano Therapeutics Announces Closing of $30.5 Million Initial Public Offering

14/02/2019 - 22:40

CAMBRIDGE, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”) today announced that it has closed its initial public offering of 2,652,174 of its American Depositary [...]

Retrophin to Present at the 8th Annual SVB Leerink Global Healthcare Conference

14/02/2019 - 22:30

SAN DIEGO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Eric Dube, Ph.D., chief executive officer, will present at the 8 th Annual SVB Leerink Global Healthcare Conference in New [...]

Paratek Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference

14/02/2019 - 22:05

BOSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]

Guardant Health to Present at the 8th Annual Leerink Partners Global Healthcare Conference

14/02/2019 - 22:05

REDWOOD CITY, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast [...]